Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: Haplotype study in French AT families

British Journal of Cancer

Volumn 80, Issue 7, 1999, Pages 1042-1045

  Janin, N ^a   Andrieu, N ^a   Ossian, K ^a   Lauge A ^b   Croquette, M F ^c   Griscelli C ^d   Debre M ^d   Bressac De Paillerets, B ^a   Aurias, A ^b   Stoppa Lyonnet, D ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

^c Centre Hospitalier Feron Vrau   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Ataxia telangiectasia heterozygosis; Breast cancer risk; Family study

Indexed keywords

MICROSATELLITE DNA;

ADOLESCENT; ADULT; ARTICLE; ATAXIA TELANGIECTASIA; BLOOD SAMPLING; BREAST CANCER; CANCER RISK; CHILD; DEMOGRAPHY; DISEASE ASSOCIATION; DNA DETERMINATION; FAMILY; FEMALE; FRANCE; HAPLOTYPE; HETEROZYGOSITY; HUMAN; IONIZING RADIATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RADIATION EXPOSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATAXIA TELANGIECTASIA; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HAPLOTYPES; HETEROZYGOTE; HETEROZYGOTE DETECTION; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT;

EID: 0032926569     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690460     Document Type: Article

References (23)

1. Aitken J, Bain C, Ward M, Siskind V and MacLennan R (1995) How accurate is self-reported family history of colorectal cancer? Am J Epidemiol 141: 863-871
2. Appleby JM, Barber JBP, Levine E, Varley JM, Taylor AMR, Stankovic T, Heighway J, Warren C and Scott D (1997) Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer 72: 1546-1549
3. Athma P, Rappaport R and Swift M (1996) Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130-134
4. Bebb G, Glickman B, Gelmon K and Gatti R (1997) 'AT risk' for breast cancer. Lancet 349: 1784-1785
5. Benhamou E, Laplanche A, Wartelle M, Faivre J, Gignoux M, Menegoz F, Robillard J, Schaffer P, Schraub S and Flamant R (1990) Incidence des cancers en France 1978-1982. In Statistiques de santé, INSERM (ed). INSERM: Paris
6. Bishop DT and Hopper J (1997) AT-tributable risk? Nat Genet 15: 226
7. Børresen AL, Andersen TI, Tretli S, Heiberg A and Moller P(1990) Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. Genes Chromosomes Cancer 2: 339-403
8. Breslow NE and Day NE (1987) The design and analysis of cohort studies. In Statistical Methods in Cancer Research, Davis W (ed). IARC: Lyon
9. Coleman M, Douglas A, Hermon C and Peto J (1986) Cohort study analysis with a Fortran computer program. Int J Epidemiol 15: 134-137
10. De Vathaire F, Koscielny S, Rezvani A, Laplanche A, Estève J and Ferlay J (1996) Estimation de l'incidence des cancers en France 1983-1987. In Statistiques de santé, INSERM (ed). INSERM: Paris
11. Easton DF (1994) Cancer risks in A-T heterozygotes. Int J Radiat Biol 6: S177-182
12. FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ and Haber DA (1997) Heterozygous ATM mutations do not contribute to early onset of breast cancer. Nat Genet 15: 307-310
13. Kelsey JL and Horm-Ross PL (1993) Breast cancer: magnitude of the problem and descriptive epidemiology. Epidemiol Rev 15: 7-16
14. Laake K, Odegard A, Andersen TI, Bukholm IK, Kaeresen R, Nesland JM, Ottestad L, Shiloh Y and Børresen-Dale AL (1997) Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM. Genes Chromosomes Cancer 18: 175
15. Morrell D, Chase CL and Swift M (1990) Cancers in 44 families with ataxia-telangiectasia. Cancer Genet Cytogenet 50: 119-123
16. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J and Powel J (1992) Cancer incidence in Five Continents. Vol 5. IARC: Lyon
17. Pippard EC, Hall AJ, Barker DJ and Bridges BA (1988) Cancer in homozygotes and heterozygotes of ataxia-telangiectasia and xeroderma pigmentosum in Britain. Cancer Res 48: 2929-2932
18. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Pantanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SH, Lovett M, Collins FS and Shiloh Y (1995) A single ataxia-telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753
19. Shayeghi M, Seal S, Regan J, Collins N, Barfoot R, Rahman N, Ashton A, Moohan M, Wooster R, Owen R, Bliss JM, Stratton ME and Yarnold J (1998) Heterozygosity for mutations in the ataxia telangectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br J Cancer 78: 922-927
20. Stankovic T, Kidd AMJ, Sutcliffe A, McGuire GM, Robinson P, Weber P, Bedenham T, Bradwell AR, Easton DF, Lennox GG, Haites N, Byrd PJ and Taylor AM (1998) ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet 62: 334-345
21. Swift M, Reitnauer PJ, Morrell D and Chase CL (1987) Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 316: 1289-1294
22. Swift M, Morrell D, Massey RB and Chase CL (1991) Incidence of cancer in 161 families affected by ataxia-telangiectasia. N Engl J Med 325: 1831-1836
23. Theis B, Boyd N, Lockwood G and Trickler D (1994) Accuracy of family history in breast cancer patients. Eur J Cancer Prev 3: 321-327